![](/img/cover-not-exists.png)
The dual orexin receptor antagonist daridorexant does not affect the pharmacokinetics of the BCRP substrate rosuvastatin
Zenklusen, Isabelle, Muehlan, Clemens, Ulc, Ivan, LiÅ¡ka, JiÅÃ, Dingemanse, JasperJournal:
Clinical and Experimental Pharmacology and Physiology
DOI:
10.1111/1440-1681.13370
Date:
June, 2020
File:
PDF, 10.04 MB
2020